Skip to main content
SpringerLink
Log in

Motilitätswirksame Medikamente

  • Conference paper
Refluxtherapie

Part of the book series: Interdisziplinäre Gastroenterologie ((GASTROENTEROLOG))

  • 42 Accesses

Zusammenfassung

Die Motilität des Oesophagus wird durch eine große Anzahl von Medikamenten verschiedener Substanzgruppen beeinflußt (Tabelle 1). Für die Therapie der gastrooesophagealen Refluxkrankheit sind jedoch nur wenige der auf die Motilität wirkenden Substanzen prinzipiell geeignet. Dies sind abgesehen von den Antacida (s. Kap. 13), folgende Pharmaka:

  • Direkte Parasympathomimetica wie Bethanechol, Carbachol, Methacholin;

  • Metoclopramid und sein Derivat Bromoprid;

  • Domperidon.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Baeyens R, van de Velde E, De Schepper A, Wollaert F (1979) Effects of intravenous and oral domperidone on the motor function of the stomach and small intestine. Postgrad Med J 55: [Suppl 1] 19–23

    CAS  Google Scholar 

  2. Behar J, Biancani P (1976) Effect of oral metoclopramide on gastroesophageal reflux in the post-cibal state. Gastroenterology 70: 331–335

    PubMed  CAS  Google Scholar 

  3. Behar J, Ramsby G (1978) Gastric emptying and antral motility in reflux esophagitis. Effect of oral metoclopramide. Gastroenterology 74: 253–256

    Google Scholar 

  4. Bettarello A, Tuttle SG, Grossman MI (1960) Effect of autonomic drugs on gastroesophageal reflux. Gastroenterology 39: 340–346

    Google Scholar 

  5. Bright-Asare P (1979) Comparative Effects of Cimetidine (CM) vs Metoclopramide (M) vs Placebo (PL) in gastroesophageal reflux disease (GERD) (Abstract). Gastroenterology 76: 973

    Google Scholar 

  6. Brock-Utne JG, Dimopoulos GE, Downing JW, Rubin J, Moshal MG (1978) A new benzimidazole (domperidone) effect on lower esophageal sphincter in late pregnancy. The Bi-Annual S.A. Congress of Anaesthesiology in Cape Town, September 23–30

    Google Scholar 

  7. Broekaert A (1979) Effect of domperidone on gastric emptying and secretion. Postgrad Med J [Suppl 1] 55: 11–14

    CAS  Google Scholar 

  8. Bron B, Massih L (1979) Le domperidon: un tricyclique capable de stimuler puissament et de facon prolongee la contraction du sphincter oesophagien inferieur. Janssen Pharmaceutica Dokumentation, Beerse (Belgien )

    Google Scholar 

  9. Casteels-van Dade M, Jaeken J, Van der Schueren P. et al. (1970) Dystonic reactions in children caused by metoclopramide. Arch Dis Child 45: 130–133

    Article  Google Scholar 

  10. Christensen J (1976) Effects of drugs on esophageal motility. Arch Intern Med 136: 532–537

    Article  PubMed  CAS  Google Scholar 

  11. Cohen S, Morris DW, Schoen HJ, DiMarino AJ (1976) The effect of oral and intravenous metoclopramide on human lower esophageal sphincter pressure. Gastroenterology 70: 484–487

    PubMed  CAS  Google Scholar 

  12. Connell AM, George JD (1969) Effect of metoclopramide on gastric function in man. Gut 10: 678–680

    Article  PubMed  CAS  Google Scholar 

  13. Dilawari JB, Misiewicz JJ (1973) Action of oral metoclopramide on the gastroesophageal junction in man. Gut 14: 380–382

    Article  PubMed  CAS  Google Scholar 

  14. Eckardt V: Unpublished data

    Google Scholar 

  15. Ennis C, Schnieden H, Cox B (1978) Effects of the antiemetic drug domperidone on guinea-pig isolated gastrointestinal tissue. J Pharm Pharmacol 30: 34

    Article  Google Scholar 

  16. Farrell RL, Roling GT, Castell DO (1973) Stimulation of the incompetent lower esophageal sphincter. A possible advance in therapy of heartburn. Dig Dis Sci 18: 646–650

    Google Scholar 

  17. Farrell RL, Roling GT, Castell DO (1974) Cholinergie therapy of chronic heartburn. Ann Intern Med 80: 573–576

    PubMed  CAS  Google Scholar 

  18. Fox S, Behar J (1979) Control of lower oesophageal sphincter pressure and acid reflux. Clin. Gastroenterol 8: 37–52

    Google Scholar 

  19. Gordon SJ, Joseph RE, Kinsey MD (1979) A preliminary clinical evaluation of domperidone (DP), a new agent with dopamine-blocking effects ( Abstract ). Gastroenterology 76: 1141

    Google Scholar 

  20. Guelrued M (1974) Effect of intravenous metoclopramide on the incompetent lower esophageal sphincter. Am J Gastroenterol 61: 119–124

    Google Scholar 

  21. Hall AW, Moossa AR, Clark J, Cooly GR, Skinner DB (1975) The effects of premedication drugs on the lower oesophageal high pressure zone and reflux status of Rhesus monkeys and man. Gut 16: 347–352

    Article  PubMed  CAS  Google Scholar 

  22. Hancock, BD, Bowen-Jones E, Dixon R, Dymock IW, Cowley DJ (1974) The effect of metoclopramide on gastric emptying of solid meals. Gut 15: 462–467

    Article  PubMed  CAS  Google Scholar 

  23. Hay AM, Man WK (1979) Effect of metoclopramide on guinea-pig stomach. Critical dependence on intrinsic stores of acetylcholine. Gastroenterology 76: 492–496

    Google Scholar 

  24. Heitmann P, Möller N (1970) The effect of metoclopramide on the gastroesophageal junctional zone and the distal esophagus in man. Scand J Gastroenterol 5: 621–625

    CAS  Google Scholar 

  25. Higgs RH, Humphries TJ, Castell DO, McGuigan JE (1976) Lower esophageal sphincter pressures and serum gastrin levels after cholinergie stimulation. Am J Physiol 231: 1250–1253

    PubMed  CAS  Google Scholar 

  26. Jacoby HI, Brodie DA (1967) Gastrointestinal actions of metoclopramide. Gastroenterology 52: 676–684

    PubMed  CAS  Google Scholar 

  27. Jennewein HM, Waldeck F (1976) Pharmakologie des unteren Oesophagussphinkters. In: Siewert R, Blum HL, Waldeck F (Hrsg) Funktionsstörungen der Speiseröhre. Springer Berlin Heidelberg New York, S 53–61

    Google Scholar 

  28. Johnson AG (1971) The action of metoclopramide in human gastroduodenal motility. Gut 12: 421–426

    Article  PubMed  CAS  Google Scholar 

  29. Kantrowitz PA, Siegel CI, Hendrix TR (1966) Differences in motility of the upper and lower esophagus in man and its alteration by atropine. Bull John Hopkins Hosp 118: 476–491

    CAS  Google Scholar 

  30. Kaya MD, Mehta SJ, Showalter JP (1976) Studies of the human pylorus. Gastroenterology 70: 477–480

    Google Scholar 

  31. Kilbinger H (to be published) The effect of metoclopramide on the guinea-pig ileum: Mediated by acetylcholine release?

    Google Scholar 

  32. Koelle GB (1975) Parasympathomimetic agents. In: Goodman, Gilman (eds) The pharmacological basis of therapeutics. Macmillan, New York Toronto London, pp 467–476

    Google Scholar 

  33. Laduron PM, Leysen JE (1979) Domperidone, a specific in vitro dopamine antagonist, devoid of in vivo central dopaminergic activity. Biochem Pharmacol 28: 2161–2165

    Article  PubMed  CAS  Google Scholar 

  34. Leonhardt I, Gehrls D, Wiemann H (1979) Cascapride, ein neues Präparat mit synchronisierender Wirkung auf die Motilität im Gastrointestinaltrakt. Therapiewoche 25: 3–7

    Google Scholar 

  35. Lind JF, Crispin JS, McIver DA (1967) The effect of atropine on the gastroesophageal sphincter. Can J Physiol Pharmacol 46: 233–238

    Article  Google Scholar 

  36. Mantelmacher H, Bettarello A (in Vorbereitung) Manometrische Bestimmung von Bromoprid auf den unteren Oesophagussphinkter.

    Google Scholar 

  37. McCallum RW, Kline MM, Curry N, Sturdevant RAL (1975) Comparative effects of metoclopramide and bethanechol on lower esophageal sphincter pressure in reflux patients. Gastroenterology 68: 1114–1118

    PubMed  CAS  Google Scholar 

  38. McCallum RW, Sowers JR, Hershman JM et al. (1976) Metoclopramide stimulates prolactin secretion in man. J Clin Endocrinol Metab 42: 1148–1152

    Article  PubMed  CAS  Google Scholar 

  39. McCallum RW, Ippoliti AF, Cooney C, Sturdevant RAL (1977) A controlled trial of metoclopramide in symptomatic gastroesophageal reflux. N Engl J Med 296: 354–357

    Article  PubMed  CAS  Google Scholar 

  40. Meeroff JC (1974) The effect of metoclopramide on human gastric emptying and secretion. Acta Gastroenterol Latinoam 6: 55–61

    PubMed  CAS  Google Scholar 

  41. Metzger WH, Cano R, Sturdevant RAL (1976) Effect of metoclopramide in chronic gastric retention after gastric surgery. Gastroenterology 71: 30–32

    PubMed  CAS  Google Scholar 

  42. Miller WN, Ganeshappa KP, Dodds WJ, Hogan WJ, Barreras RF, Arndorfer RC (1977) Effect of bethanechol on gastroesophageal reflux. Dig Dis Sci 22: 230–234

    Article  CAS  Google Scholar 

  43. Misiewicz JJ (1974) Clinical pharmacology and therapeutics of the oesophagus and the lower oesophageal sphincter. Postgrad Med J 50: 194–197

    Article  PubMed  CAS  Google Scholar 

  44. Niemann H, Jakob G (1971) Die Testung von Spasmolytika mittels der Oesophagusmanometrie beim Mensch. Arzneim Forsch 21: 1217–1221

    CAS  Google Scholar 

  45. Paull A, Kerr Grant A (1974) Controlled trial of metoclopramide in reflux oesophagitis. Med J Aust 2: 627–629

    PubMed  CAS  Google Scholar 

  46. Peringer E, Jenner P, Marsden CD (1975) Effect of metoclopramide on turnover of brain dopamine nonadrenaline and 5-hydroxytryptamine J Pharm Pharmacol 27: 442–444

    CAS  Google Scholar 

  47. Pflücke F, Arendt R (1977) The effect of metoclopramide on gastro-oesophageal reflux. Tijdschr Gastroenterol 20: 155–162

    PubMed  Google Scholar 

  48. Phaosawasdi K, Malmud LS, Stelzer FA, Tolin RD, Reilley J, Fisher RS (1979) Cholinergic effects on esophageal clearance and transit ( Abstract ). Gastroenterology 76: 12–17

    Google Scholar 

  49. Pinder RM, Brogden RN, Sawyer PR, Speight TM, Avery GS (1976) Metoclopramide: a review of its pharmacological properties and clinical use. Drugs 12: 81–131

    Article  PubMed  CAS  Google Scholar 

  50. Reid M (1977) Dystonic reactions to metoclopramide (Maxolon). Ulster Med J 46: 38–40

    PubMed  CAS  Google Scholar 

  51. Rösch W, Engel J, Lux G (1979) Doppelblind-cross-over-Studie. Domperidon vs. Metoclopramid vs. Bromoprid und LESP. 34. Tagung d. Dtsch. Ges. für Verdauungs- und Stoffwechselkrankh. Garmisch Partenkirchen.

    Google Scholar 

  52. Roling GT, Farrell RL, Castell DO (1972) Cholinergic response of the lower esophageal sphincter. Am J Physiol 222: 967–972

    PubMed  CAS  Google Scholar 

  53. Schmidt GF, Engel Th, Bauer H, Doenicke A (1978) Der Einfluß von Domperidon und Metoclopramid auf die Antrummotilität. Anaesthesist 27: 427–429

    PubMed  CAS  Google Scholar 

  54. Schulze-Delrieu K (1979) Metoclopramide. Gastroenterology 77: 768–779

    CAS  Google Scholar 

  55. Sehhati G (1977) Die Wirkung von Praemedikationsmitteln auf den unteren Oesophagussphinkter (UÖS). Anaesthesist 26: 489–492

    CAS  Google Scholar 

  56. Shepard JK, Diamant NE (1972) Mecholyl test: Comparison of balloon kymography and intraluminal pressure measurement. Gastroenterology 63: 557–563

    Google Scholar 

  57. Sjodin L, Nelsson G (1974) Plasma gastrin levels and gastric acid secretion in dogs during administration of urecholine. Scand J Gastroenterol 9: 947–950

    Google Scholar 

  58. Stanciu C, Bennet JR (1973) Metoclopramide in gastroesophageal reflux. Gut 14: 275279

    Google Scholar 

  59. Thiel H, Karaletsos D (1976) Zum Einfluß von Metoclopramid auf die basale und mahl-zeitstimulierte Gastrinsekretion beim Magengesunden. Verh Dtsch Ges Inn Med 82: 1010–1014

    PubMed  CAS  Google Scholar 

  60. Valenzuela J (1981) Effects of domperidone on the symptoms of reflux oesophagitis. Roy Soc Med Int Congr Ser Nr 36: 51–56

    Google Scholar 

  61. Valenzuela JE, Defilippi C, Csendes A (1976) Manometric studies on the human pyloric sphincter: effect of cigarette smoking, metoclopramide and atropine. Gastroenterology 70: 481–483

    PubMed  CAS  Google Scholar 

  62. Van Nueten JM, Ennis Ch, Helsen L, Laduron PM, Janssen PAJ (1978) Inhibition of dopamine receptors in the stomach: An explanation of the gastrokinetic properties of domperidone. Life Sci 23: 453–458

    Google Scholar 

  63. Vantrappen G (1977) Effect of domperidone and metoclopramide on lower esophageal sphincter pressure (LESP). A double-blind placebo-controlled cross-over study in healthy volunteers. Janssen, Beerse

    Google Scholar 

  64. Venables CW, Bell D, Eccleston D (1973) A double-blind study of metoclopramide in symptomatic peptic oesophagitis. Postgrad Med J [Suppl 4] 49: 73–76

    Article  Google Scholar 

  65. Weihrauch TR, Waldeck F, Förster ChF, Ewe K (1978) Die Wirkung von Fenoterol auf den Oesophagussphinktertonus bei Achalasie. Verh Dtsch Ges Inn Med 84: 979–982

    PubMed  Google Scholar 

  66. Weihrauch TR, Korting GW, Ewe K, Vogt E (1978) Esophageal dysfunction and its pathogenesis in progressive systemic sclerosis. Klin Wochenschr 56: 963–968

    Article  PubMed  CAS  Google Scholar 

  67. Weihrauch TR, Korting GW, Förster ChF, Köhler H, Ewe K, Krieglstein J (1979) Effect of intravenous diazepam on human lower oesophageal sphincter pressure under controlled double blind crossover conditions. Gut 20: 64–67

    Article  PubMed  CAS  Google Scholar 

  68. Weihrauch TR, Förster ChF, Krieglstein J (1979) Evaluation of the effect of domperidone on human oesophageal and gastroduodenal motility by intraluminal manometry. Postgrad Med J [Suppl 1] 55: 7–10

    CAS  Google Scholar 

  69. Weihrauch TR, Förster ChF, Ehl E (1979) The pylorus in man: Is its competence only a question of adequate closure timing (Abstract)? Gastroenterology 76: 12–68

    Google Scholar 

  70. Weiser HF, Lepsien G, Golenhofen K, Schattenmann G, Siewert R (1977) Klinische und experimentelle Untersuchungen zur Wirkung von Nifedipine auf die glatte Muskulatur des Ösophagus. Z Gastroenterol 11: 691–698

    Google Scholar 

  71. Wienbeck M, Bovelet M, Hausamen TU, Strohmeyer G (1976) Beeinflussung des unteren Ösophagussphinkters durch Phenylalanin-Lysin-Vasopressin. Mögliche Auswirkungen auf blutende Oesophagusvarizen. Z Gastroenterol 14: 333–341

    Google Scholar 

  72. Zfass AM, Prince R, Allen FN, Farrar JT (1970) Inhibitory ß-adrenergic receptors in the human distal esophagus. Am J Dig Dis 15: 303–310

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. T. R. Weihrauch
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Allgemeinchirurgie, Georg-August-Universität Göttingen, Robert-Koch-Straße 40, D-3400, Göttingen, Germany

    Jörg Rüdiger Siewert

  2. Medizinische Klinik, Stadtspital Triemli, Birmendorfstraße 497, CH-8063, Zürich, Switzerland

    André Louis Blum

Rights and permissions

Reprints and permissions

Copyright information

© 1981 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Weihrauch, T.R. (1981). Motilitätswirksame Medikamente. In: Siewert, J.R., Blum, A.L. (eds) Refluxtherapie. Interdisziplinäre Gastroenterologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67714-4_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-67714-4_16

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-10179-6

  • Online ISBN: 978-3-642-67714-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation